Gosset Beta-endorphin Overview
Beta-endorphin is a 31-amino acid endogenous opioid neuropeptide and peptide hormone derived from the precursor protein pro-opiomelanocortin (POMC) in pituitary corticotrophs and hypothalamic neurons, particularly the arcuate nucleus[3][4][5]. It acts as a potent agonist at μ-opioid receptors, functioning both as a neuromodulator and neurotransmitter to regulate pain, inhibit hormone and neurotransmitter release, and modulate stress and reward pathways[2][4][5]. Beta-endorphin is released in the hypothalamus and pituitary in response to pain, stress, and diverse rewarding stimuli (e.g., exercise, food, sex)[2][4][6][7]. It plays a role in adaptive behaviors by lowering pain perception, inducing euphoria, and regulating the body's response to stress and negative emotions[6][7]. Dysregulation of beta-endorphin is associated with mood disorders, chronic pain, and addiction[3][6].
Mechanism of Action
Endogenous ligand binding to μ-opioid receptor (agonist); Inhibition of neurotransmitter (e.g., GABA, substance P) release; Modulation of dopamine pathways via GABAergic mechanisms
Biological Functions
Disease Associations
Safety Considerations
- Disruption of normal pain and stress regulation pathways
- Potential for altered mood, addiction, or dependence from dysregulation
- Deficiency linked to mood disorders, excess linked to blunted pain responses
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| β-endorphin levels (plasma, cerebrospinal fluid) |
| Activity of proopiomelanocortin (POMC) processing enzymes (e.g., prohormone convertase 1) |